TIP120A Inhibitors

TIP120A inhibitors encompass a diverse group of chemicals that either directly target TIP120A, Cullin-Associated and Neddylation-Dissociated 1, or indirectly influence its function through various cellular mechanisms. The primary mode of action for these inhibitors is disrupting the interaction between TIP120A and cullin-RING ligases (CRLs) or affecting the neddylation process. Inhibitors like MLN4924 and Pevonedistat act by targeting the NEDD8-activating enzyme, a crucial step in the neddylation of cullins, which is essential for the activation of CRLs. By inhibiting this enzyme, these compounds prevent the activation of CRLs, thereby indirectly modulating the function of TIP120A.

Other inhibitors work by targeting different aspects of the ubiquitin-proteasome pathway or related cellular processes. Compounds such as Bortezomib and MG132 are proteasome inhibitors that block the degradation of proteins, a process that is regulated by CRLs and thus indirectly influenced by TIP120A. Curcumin, although not a specific inhibitor, affects multiple cellular pathways including the ubiquitin-proteasome system and can therefore influence TIP120A functions. Thalidomide and its derivatives, including Pomalidomide and Lenalidomide, modulate the activity of ubiquitin ligases, which play a crucial role in protein degradation pathways overseen by TIP120A. Furthermore, some inhibitors, like VX-11e, Auranofin, Sorafenib, and Rapamycin, target different signaling pathways or enzymes but can indirectly impact TIP120A functions due to the interconnected nature of cellular processes. VX-11e, as an ERK inhibitor, affects signaling pathways that might interact with the ubiquitin-proteasome system. Auranofin inhibits thioredoxin reductase, influencing various processes including those regulated by TIP120A. Sorafenib and Rapamycin target kinases and mTOR, respectively, altering cellular signaling and growth processes that could intersect with the regulatory roles of TIP120A.